These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 20483052)

  • 1. Efficacy of abatacept in a refractory case of adult-onset Still's disease.
    Quartuccio L; Maset M; De Vita S
    Clin Exp Rheumatol; 2010; 28(2):265-7. PubMed ID: 20483052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory adult-onset still disease successfully treated with abatacept.
    Ostrowski RA; Tehrani R; Kadanoff R
    J Clin Rheumatol; 2011 Sep; 17(6):315-7. PubMed ID: 21869709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset Still's disease: Advances in the treatment.
    Castañeda S; Blanco R; González-Gay MA
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
    Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
    Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anakinra in refractory adult onset Still's disease].
    Vercoutere W; Starmans-Kool M; Peeters RM
    Ned Tijdschr Geneeskd; 2011; 155(18):A2966. PubMed ID: 21466723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult onset Still's disease-The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review).
    Junge G; Mason J; Feist E
    Semin Arthritis Rheum; 2017 Oct; 47(2):295-302. PubMed ID: 28757235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
    Tamaki H; Shimizu H; Hiraoka E; Uechi E; Kishimoto M; Yamaguchi K; Okada M
    Mod Rheumatol; 2010 Apr; 20(2):200-4. PubMed ID: 20037747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra).
    Fischer-Betz R; Specker C; Schneider M
    Clin Exp Rheumatol; 2011; 29(6):1021-3. PubMed ID: 22153586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of methotrexate in adult-onset Still's disease.
    Manger B; Rech J; Schett G
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S168-71. PubMed ID: 21044454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
    Fitzgerald AA; Leclercq SA; Yan A; Homik JE; Dinarello CA
    Arthritis Rheum; 2005 Jun; 52(6):1794-803. PubMed ID: 15934079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with tocilizumab in a patient with refractory adult-onset Still's disease (AOSD).
    Yoshimura M; Makiyama J; Koga T; Miyashita T; Izumi Y; Torigoshi T; Motokawa S; Eguchi K; Migita K
    Clin Exp Rheumatol; 2010; 28(1):141-2. PubMed ID: 20346255
    [No Abstract]   [Full Text] [Related]  

  • 14. Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
    Sfriso P; Bindoli S; Galozzi P
    Drugs; 2018 Aug; 78(12):1187-1195. PubMed ID: 30069732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease.
    Asano T; Furuya MY; Sato S; Kobayashi H; Watanabe H; Suzuki E; Migita K
    BMC Res Notes; 2018 May; 11(1):320. PubMed ID: 29784018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
    Efthimiou P; Kontzias A; Hur P; Rodha K; Ramakrishna GS; Nakasato P
    Semin Arthritis Rheum; 2021 Aug; 51(4):858-874. PubMed ID: 34175791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
    Colafrancesco S; Manara M; Bortoluzzi A; Serban T; Bianchi G; Cantarini L; Ciccia F; Dagna L; Govoni M; Montecucco C; Priori R; Ravelli A; Sfriso P; Sinigaglia L;
    Arthritis Res Ther; 2019 Dec; 21(1):275. PubMed ID: 31829244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical form of Adult-onset Still's Disease with Distal Interphalangeal Joints Involvement.
    Belghali S; El Amri N; Baccouche K; Laataoui S; Bouzaoueche M; Zeglaoui H; Bouajina E
    Curr Rheumatol Rev; 2018; 14(3):284-288. PubMed ID: 28758587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of refractory adult onset Still's disease with rituximab.
    Belfeki N; Smiti Khanfir M; Said F; Hamzaoui A; Ben Salem T; Ben Ghorbel I; Lamloum M; Houman MH
    Reumatismo; 2016 Dec; 68(3):159-162. PubMed ID: 27981819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic treatments for adult-onset Still's disease.
    Al-Homood IA
    Rheumatology (Oxford); 2014 Jan; 53(1):32-8. PubMed ID: 23864171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.